Arabic Arabic English English French French German German
dark

Pfizer seeks conditional EU authorization for COVID-19 pill

The European drug regulator said Monday it has started evaluating an application by Pfizer for its pill to treat the effects of COVID-19. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Cancer therapy using on-site synthesis of anticancer drugs

Next Post

T-cells: The superheroes in the battle against omicron

Related Posts
Total
0
Share